ClinicalTrials.gg
RecruitingNCT07623772Updated Nov 4, 2026

Confident Moves Intervention Efficacy Trial: Obesity Care Settings

An interventional study of Confident Moves (CM) Intervention in Obesity and Overweight, sponsored by Iowa State University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Iowa State University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Updated Nov 4, 2026Now RecruitingFirst site in United States+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
348
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The objective of this study is to evaluate the efficacy of the Confident Moves (CM) intervention on device-measured physical activity (PA) and the whole person health index in adults with obesity, compared to standard obesity care alone. Confident Moves (CM) is a web-based physical activity (PA)-promoting research intervention developed by the study team to support adults with obesity. CM is not a medical or clinical treatment; rather, it is designed to promote daily PA through structured, self-paced online learning activities. The intervention has been previously pilot-tested in a feasibility study, which demonstrated its acceptability, safety, and feasibility and informed refinements to study procedures. CM aims to strengthen participants' confidence, knowledge, and behavioral skills related to PA across multiple everyday contexts. The intervention is delivered through a secure, ISU-managed website, with access limited to enrolled participants and authorized research personnel. Only study staff have access to participant data, and data are used solely for research purposes.

02

Conditions studied

  • Obesity
  • Overweight

Keywords

  • eHealth
  • Internet applications
  • information and communication technologies
  • exercise
03

In context

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

This study's planned enrollment of 348 is above the median of 67 across 9,043 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Iowa State University is the lead sponsor of 37 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-64 years
  • (BMI) ≥ 25 kg/m²
  • Access to a technological device (e.g., computer, smartphone) capable of supporting the online intervention
  • Not currently enrolled in another physical activity (PA) intervention (except standard obesity care programs at participating centers)
  • Willingness to wear a wrist worn accelerometer for two separate 7 day monitoring periods
  • Willingness to respond to study related communications (e.g., email, text, phone call)

Exclusion criteria

Exclusion Criteria:

- Failure to meet one or more of the inclusion criteria

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
348 participants (estimated)

Study arms

  • No intervention
    Standard Care Group

    Participants assigned to the standard care group will receive only the obesity centers' standard obesity care program during the data collection period. They will be provided with login credentials to access the CM website for data collection at wave 1 (W1), wave 2 (W2), and wave 3 (W3).

  • Experimental
    CM Group

    Participants assigned to the Confident Moves (CM) group also will receive the obesity centers' program and will be provided with 4 weeks of continuous (24-hour) access to the CM intervention during the data collection period. Access to the CM intervention will become available between W1 and W2, and those in this group will be notified via email. They will be encouraged to actively engage with the intervention, including completing at least 26 intervention challenges. They will be provided with login credentials to access the CM website for both the CM intervention and data collection at W1, W2, and W3.

    Behavioral: Confident Moves (CM) Intervention

Interventions

  • BehavioralConfident Moves (CM) Intervention

    Confident Moves (CM) is a web-based physical activity (PA) intervention designed to integrate with obesity care and support daily PA in adults with obesity. A 2025 feasibility trial supported the development of a future randomized controlled trial and identified areas for refinement. Grounded in social cognitive theory, CM targets self-efficacy through structured learning activities such as games, videos, lectures, and self-reflection, incorporating behavior change techniques like goal setting and action planning. The online program includes seven components addressing multiple PA domains and mindfulness, delivered over 4 weeks with flexible access.

    Also known as: Physical Activity Self-efficacy (PAS) Intervention

06

What researchers measure

Primary outcomes

  1. ActiGraph wGT3X-BT

    Device-measured physical activity (PA) will be assessed at W1 and W3 using the ActiGraph wGT3X-BT (Pensacola, FL, USA), a tri-axial research-grade accelerometer. Devices will collect data at 30 Hz and be reintegrated into 60-s epochs. Non-wear will be defined as ≥90 consecutive minutes of zero counts, allowing ≤2 min of nonzero counts if surrounded by ≥30 min of zeros. Data will be considered valid if participants have ≥3 days with ≥10 h/day of wear, no device malfunction, and consistency with logs. Moderate-to-vigorous PA (MVPA) will be defined as ≥3,941 counts/min using wrist-specific vector magnitude cut-points validated in free-living adults.

    Time frame: At W1 (Week 1-4) and W3 (Week 13-16)

  2. Whole Person Health Index (WPHI) scale

    The Whole Person Health Index (WPHI) will be measured at W1 and W3 using a 9-item self-reported scale developed by the National Center for Complementary and Integrative Health, in collaboration with the Centers for Disease Control and Prevention. The WPHI assesses overall health across physical, psychological, and social domains, reflecting a whole person health framework beyond disease-specific outcomes. Items assess general health, quality of life, social/family connections, diet, physical activity, stress management, sleep, meaning/purpose, and ability to manage health, rated on a 5-point Likert scale (1=poor to 5=excellent). The WPHI is validated and used in observational and clinical studies, including the 2025 National Health Interview Survey. Total scores range from 9 to 45, with higher scores indicating better health outcomes.

    Time frame: At W1 (Week 1-4) and W3 (Week 13-16)

Secondary outcomes

  1. Physical Activity Self-Efficacy (PASE) scale

    Physical Activity Self-Efficacy (PASE) will be assessed at W1 and W2 using a 36-item self-reported scale measuring confidence in achieving recommended weekly physical activity (PA). PASE evaluates self-efficacy across four domains: occupational, transport, domestic, and leisure PA. Occupational and leisure domains include moderate- and vigorous-intensity activities, whereas transport and domestic domains include moderate-intensity activities only. Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence), consistent with standard self-efficacy measures. Total scores range from 0 to 144, with higher scores indicating greater PA self-efficacy.

    Time frame: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  2. Self-Efficacy to Regulate Physical Activity (SERPA) scale

    Self-efficacy to regulate physical activity (SERPA) will be measured at W1 and W2 using a 13-item version of the SERPA scale. This scale will assess participants' confidence in their ability to overcome barriers to sustaining weekly PA. Previous measurement studies of the SERPA scale indicate a two-factor structure reflecting different types of barriers to PA. Items are rated on a five-point self-efficacy scale (0 = no confidence to 4 = complete confidence). Total scores range from 0 to 52, with higher scores indicating better outcomes.

    Time frame: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  3. Self-Efficacy for Whole Person Health (SE-WPH) scale

    Self-Efficacy for Whole Person Health (SE-WPH) will be measured at W1 and W2 using a newly developed 9-item self-reported scale. The SE-WPH assesses confidence in engaging in and sustaining behaviors that support whole person health across physical, psychological, and social domains, aligned with the Whole Person Health Index (WPHI). Items reflect key areas including overall health and quality of life, social connections, health behaviors (diet, physical activity, sleep, stress), and health self-management. Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence). Psychometric evaluation (reliability and validity) will be conducted prior to hypothesis testing. Total scores range from 0 to 36, with higher scores indicating greater self-efficacy.

    Time frame: [Time Frame: At W1 (Week 1-4) and W2 (Week 9)]

  4. Self-Efficacy to Engage (SE-E) scale

    Self-Efficacy to Engage (SE-E) will be measured at W2 among participants in the CM group upon access to the intervention, using a previously developed 7-item self-reported scale. The SE-E assesses confidence in engaging with the online intervention and is conceptually aligned with subjective engagement. An example item is: "How confident are you in your current ability to pay close attention when engaging with this online intervention?" Items are rated on a 5-point scale (0 = no confidence to 4 = complete confidence). Although previously developed, the scale was only used in a feasibility trial; thus, reliability and validity will be evaluated prior to hypothesis testing. Total scores range from 0 to 28, with higher scores indicating greater engagement self-efficacy.

    Time frame: [Time Frame: At W2 (Week 9)]

  5. Physical Activity Outcome Expectations (PAOE) scale

    Physical Activity Outcome Expectations (PAOE) will be assessed at W1, W2, and W3 using a modified 13-item self-reported scale capturing beliefs about expected outcomes of physical activity (PA). The scale was adapted from the Multidimensional Outcome Expectations for Exercise scale, grounded in social cognitive theory and encompassing physical, social, and self-evaluative domains. Modifications were informed by responses from 30 adults with obesity in a 2025 feasibility trial, using inductive analyses and independent item review to enhance relevance to obesity-specific PA contexts. An example item is: "Physical activity will improve my stamina for daily activities." Items are rated on a 5-point scale (1 = strongly disagree to 5 = strongly agree). Psychometric evaluation will be conducted prior to hypothesis testing. Total scores range from 13 to 65, with higher scores indicating more positive outcome expectations.

    Time frame: [Time Frame: At W1 (Week 1-4), W2 (Week 9), and W3 (Week 13-16)]

  6. Subjective Engagement (SE) scale

    Subjective engagement (SE) will be assessed among participants assigned to the CM group after intervention access is provided, using a newly developed subjective engagement scale. This 7-item measure is designed to assess participants' subjective engagement with the web-based intervention, consistent with conceptualizations of engagement in the online behavioral intervention literature. An example item is: "I paid close attention when engaging with this online intervention." Responses will be recorded using a five-point Likert scale (i.e., 0 = not at all to 4 = completely). Because the engagement scale is newly developed, evidence regarding the validity and reliability of scores derived from this measure will be evaluated using data collected at W1. Total scores range from 0 to 28, with higher scores indicating better outcomes.

    Time frame: [Time Frame: W2 (Week 9)]

  7. Support from Obesity Care Centers for Physical Activity (SOCC) scale

    Support from Obesity Care Centers (SOCC) will be assessed at W1 using a 7-item self-reported scale informed by the 2025 CM feasibility trial. The SOCC assesses experiences with and perceptions of physical activity (PA)-related support received outside the CM intervention. It includes a screening item on receipt of PA support, followed by conditional items assessing type of support and satisfaction. Participants reporting support describe it in open-ended form and rate satisfaction on a 5-point scale (1 = very dissatisfied to 5 = very satisfied). Additional items assess referrals to PA resources and perceived preferences, needs, and barriers. Data will be used descriptively to contextualize PA support and inform intervention refinement. Total scores range from 7 to 35, with higher scores indicating greater perceived support.

    Time frame: [Time Frame: At W1 (Week 1-4)]

  8. International Physical Activity Questionnaire-Short Form (IPAQ-SF) scale

    Self-reported PA will be measured at W1, W2, and W3 with the short form of International Physical Activity Questionnaire (IPAQ). This questionnaire assesses the frequency and duration of walking, moderate-, and vigorous-intensity PA over the past 7 days. Average minutes per day of moderate-to-vigorous physical activity (MVPA) will be calculated based on the IPAQ guidelines.

    Time frame: [Time Frame: At W1 (Week 1-4) and W3 (Week 13-16)]

07

Study locations

1 of 1 sites recruiting
  • Iowa Specialty Hospital
    Des Moines, Iowa 50021, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Jul 2027, 12 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
May 21, 2026
First posted
Jun 3, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Jul 2027
CompletionEst.
Aug 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
1 site added — first site in United States
Show site
  • Iowa Specialty Hospital · Des Moines, United States
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Iowa Specialty Hospital · Des Moines, United States
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07623772
Lead sponsor
Iowa State University
Responsible party
Seungmin Lee (Assistant Professor, Iowa State University) — Principal investigator
First posted
Jun 3, 2026
Start date
Jul 1, 2026
Primary completion
Jul 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Seungmin Lee, PhD
Contact
seunglee@iastate.edu
515-294-8257

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion